Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
Big Business This Week: In the crypto casino, the house always wins
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Nearly 368,000 pounds of turkey bacon recalled in listeria scare
The maker of Oscar Mayer turkey bacon is recalling nearly 368,000 pounds of the product because it may be contaminated with listeria bacteria.
How a rift over regulation doomed the big bill’s ban on state AI laws
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Inventor of the cellphone has insight on future of communications
Martin Cooper changed the world when he pioneered the portable phone, which weighed four pounds at the time. What's next?
U.S. Private Payrolls Fall by 33K in June, Shaking Labor Market Optimism
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
